Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Stelara

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Stelara was produced by Johnson & Johnson.

J&J splashes $750m on anti-inflammatory drug bermekimab

J&J splashes $750m on anti-inflammatory drug bermekimab

J&J already has high stakes in the anti-inflammatory market, with its blockbuster IL-12/IL-23 inhibitor blockbuster Stelara (ustekinumab) and follow-up Tremfya (guselkumab). ... The therapy is a follow-up to its older blockbuster Stelara, which is facing

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial This includes a recent phase 3 BE VIVID study comparing the drug to Johnson &Johnson’s Stelara (ustekinumab), which bimekizumab also demonstrated superiority over.

Janssen files Tremfya for psoriatic arthritis in Europe

Janssen files Tremfya for psoriatic arthritis in Europe First approved in Europe two years ago, Tremfya (guselkumab) is the follow-up to J&J’s IL-12/IL-23 inhibitor blockbuster Stelara (ustekinumab), which is facing increased competition across ... of Stelara – which made $4.66bn in the first three

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal showed it was better at clearing skin than placebo and Johnson &Johnson’s big-selling Stelara (ustekinumab) product.

Litigation concerns threaten to overshadow solid quarter at J&J

Litigation concerns threaten to overshadow solid quarter at J&J Growth for immunology therapy Stelara (ustekinumab) and blood cancer drugs Imbruvica (ibrutinib) and Darzalex (daratumumab) – plus Stelara follow-up Tremfya (guselkumab) – outweighed the effect of generic competition to older prostate cancer

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...
Digital therapeutics and their impact on society
Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?...
Healthanuary?
Whether you are taking part in Dry January, Veganuary, or any other health regime, just keep going!...

Infographics